Eagle Pharmaceuticals, Inc.
DANTROLENE FORMULATIONS AND METHODS OF THEIR USE

Last updated:

Abstract:

The disclosure is directed to liquid formulations of dantrolene, or a pharmaceutically acceptable salt thereof, and methods of their use in the treatment of disease.

Status:
Application
Type:

Utility

Filling date:

21 May 2019

Issue date:

5 Aug 2021